February 6, 2012
William B. Bonvillian is Director of the Massachusetts Institute of Technology’s Washington, D.C. Office. On February 6, 2012, he presented, "The Organizational Challenge for Energy Technology Innovation" at the Rochester Institute of Technology. This talk detailed attempts to access evolving energy technology policy, focusing on the organizational challenges particularly at the federal government level.
January 31, 2012
David Valle, MD, PhD, is the Director of the McKusick,-Nathans Institute of Genetic Medicine at Johns Hopkins University School of Medicine. He presented a lecture entitled, "The Quest to Find and Solve All Human Mendelian Disorders: Genomics Meets Genetics," as part of the Process of Discovery course on Tuesday, January 31st.
January 30, 2012
William Gahl, MD, PhD, is the Clinical Director of the National Human Genome Research Institute at the National Institutes of Health. He presented a lecture entitled, "The National Institutes of Health - Undiagnosed Diseases Program," as part of the Process of Discovery course on Monday, January 30th, 2012.
January 17, 2012
Kurt Schilling, PhD, is currently VP, Assay R&D at Ortho Clinical Diagnostics (OCD) at Johnson & Johnson, where he leads teams in Rochester, NY and Raritan, NJ involved in the development of medical diagnostic assays and platforms. He gave a seminar entitled, "Leading Edge Trends in Medical Devices and Diagnostics: Innovation at Johnson & Johnson Ortho Clinical Diagnostics" on Tuesday, January 17, 2012. This event was sponsored by the Biomedical Engineering Department, the Center for Emerging and Innovative Sciences, and the Office of Research Alliances.
October 27, 2011
Ira Shoulson, M.D., Professor of Neurology, Pharmacology and Human Science, and Director of the Program for Regulatory Science and Medicine at Georgetown University, gave a presentation entitled, "Regulatory Science and Medicine: It's About Time!" on Thursday, October 27, 2011. The event was co-hosted by the Clinical and Translational Science Institute and the Office of Research Alliances.
October 7, 2011
Dr. Allan Goldberg, Executive Director of Academic and Professional Affairs at Merck & Co., gave a presentation entitled, "Preclinical Drug Discovery and Development" on Friday, October 7, 2011. The event was co-hosted by the University Committee for Interdisciplinary Studies in Drug Discovery and the Office of Research Alliances. For more information, click here.
September 13, 2011
Dr. Lisa Porter, Director of the Intelligence Advanced Research Projects Activity (IARPA), gave a presentation entitled, "An Overview of IARPA" on Tuesday, September 13th at Rush Rhees Library.